Associations between vitamin D receptor polymorphisms and susceptibility to Behcet’s disease: A meta-analysis

References

• Al-Nahas Z, Fawzy M, El Menyawi M, et al. (2017). 25-hydroxyvitamin D3 deficiency and vitamin D receptor polymorphisms in Egyptian patients with Behçet’s disease: a pilot study. Int J Clin Rheumtol, 12, 20–27.
   Google Scholar
• Arnson Y, Amital H, Shoenfeld Y. (2007). Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis, 66, 1137–1142.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Amento EP, Krane SM. (1986). Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol, 98, 311–322.
   PubMed Web of Science ®Google Scholar
• Bizzaro G, Antico A, Fortunato A, et al. (2017). Vitamin D and autoimmune diseases: is Vitamin D Receptor (VDR) polymorphism the Culprit? Isr Med Assoc J, 19, 438–443.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio D, Cippitelli M, Cocciolo MG, et al. (1998). Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest, 101, 252–262.
   PubMed Web of Science ®Google Scholar
• Do JE, Kwon SY, Park S, et al. (2008). Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet’s disease. Rheumatology (Oxford), 47, 840–848.
   PubMed Web of Science ®Google Scholar
• Erten G, Kalkan M, Bilgic Gazioglu S, et al. (2016). TaqI, FokI, and ApaI polymorphisms in the vitamin D receptor in Behcet’s disease in Turkish population. Dis Markers, 2016, 7475080.
   PubMedGoogle Scholar
• Gallone G, Haerty W, Disanto G, et al. (2017). Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease. Hum Mol Genet, 26, 2164–2176.
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Ben Dhifallah I, Karray E, et al. (2010). Vitamin D modulates peripheral immunity in patients with Behcet’s disease. Clin Exp Rheumatol, 28, S50–7.
   PubMed Web of Science ®Google Scholar
• Hitchon CA, Sun Y, Robinson DB, et al. (2012). Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol, 39, 1792–1797.
   PubMed Web of Science ®Google Scholar
• Kamal A, Gamal SM, Elgengehy FT, et al. (2016). Association of VDR ApaI and TaqI gene polymorphisms with the risk of scleroderma and Behcet’s disease. Immunol Invest, 45, 531–542.
   PubMed Web of Science ®Google Scholar
• Karatay S, Yildirim K, Karakuzu A, et al. (2011). Vitamin D status in patients with Behcet’s disease. Clinics (Sao Paulo), 66, 721–723.
   PubMed Web of Science ®Google Scholar
• Karray EF, Ben Dhifallah I, Ben Abdelghani K, et al. (2012). Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet’s disease in Tunisians. Joint Bone Spine, 79, 144–148.
   PubMed Web of Science ®Google Scholar
• Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, et al. (2014). The status of serum vitamin D in patients with active Behcet’s disease compared with controls. Int J Rheum Dis, 17, 430–434.
   PubMed Web of Science ®Google Scholar
• Khodadadi H, Khabazi A, Ghaderian SMH, et al. (2013). Molecular analysis of vitamin D receptor gene polymorphisms rs2228570 (FokI) and rs1544410 (BsmI) in patients with Behcet’s disease. Life Sci J, 10, 608–615.
   Google Scholar
• Kokturk A. (2012). Clinical and pathological manifestations with differential diagnosis in Behçet’s disease. Pathol Res Int, 2012, 1–9.
   Google Scholar
• Kolahi S, Khabbazi A, Khodadadi H, et al. (2015). Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behcet’s disease. Scand J Rheumatol, 44, 163–167.
   PubMed Web of Science ®Google Scholar
• Mao S, Huang S. (2014). Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis. Rheumatol Int, 34, 381–388.
   PubMed Web of Science ®Google Scholar
• Marson A, Housley WJ, Hafler DA. (2015). Genetic basis of autoimmunity. J Clin Invest, 125, 2234–2241.
   PubMed Web of Science ®Google Scholar
• Morgan JW, Kouttab N, Ford D, et al. (2000). Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology, 141, 3225–3234.
   PubMed Web of Science ®Google Scholar
• Mostowska A, Lianeri M, Wudarski M, et al. (2013). Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep, 40, 803–810.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Flint J. (2004). Meta-analysis of genetic association studies. Trends Genet, 20, 439–444.
   PubMed Web of Science ®Google Scholar
• Pike JW, Meyer MB, Bishop KA. (2012). Regulation of target gene expression by the vitamin D receptor – an update on mechanisms. Rev Endocr Metab Disord, 13, 45–55.
   PubMed Web of Science ®Google Scholar
• Rigby WF, Denome S, Fanger MW. (1987). Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest, 79, 1659–1664.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, et al. (1999). Behcet’s disease. N Engl J Med, 341, 1284–1291.
   PubMed Web of Science ®Google Scholar
• Song GG, Bae SC, Lee YH. (2016). Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Z Rheumatol, 75, 322–329.
   PubMed Web of Science ®Google Scholar
• Stefanic M, Karner I, Glavas-Obrovac L, et al. (2005). Association of vitamin D receptor gene polymorphism with susceptibility to Graves’ disease in Eastern Croatian population: case-control study. Croat Med J, 46, 639–646.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Kastner DL, Remmers EF. (2015). The immunogenetics of Behçet’s disease: a comprehensive review. J Autoimmun, 64, 137–148.
   PubMed Web of Science ®Google Scholar
• Tizaoui K, Kaabachi W, Hamzaoui A, et al. (2014a). Contribution of VDR polymorphisms to type 1 diabetes susceptibility: systematic review of case-control studies and meta-analysis. J Steroid Biochem Mol Biol, 143, 240–249.
   PubMed Web of Science ®Google Scholar
• Tizaoui K, Kaabachi W, Hamzaoui A, et al. (2015). Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol, 12, 243–252.
   PubMed Web of Science ®Google Scholar
• Tizaoui K, Kaabachi W, Ouled Salah M, et al. (2014b). Vitamin D receptor TaqI and ApaI polymorphisms: a comparative study in patients with Behcet’s disease and rheumatoid arthritis in Tunisian population. Cell Immunol, 290, 66–71.
   PubMed Web of Science ®Google Scholar
• Tsoukas CD, Watry D, Escobar SS, et al. (1989). Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab, 69, 127–133.
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG, Fang Y, Van Meurs JB, et al. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143–156.
   PubMed Web of Science ®Google Scholar
• van Etten E, Verlinden L, Giulietti A, et al. (2007). The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol, 37, 395–405.
   PubMed Web of Science ®Google Scholar
• Veldman CM, Cantorna MT, DeLuca HF. (2000). Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys, 374, 334–338.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B O’Connell D, et al. (2013). The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Whitfield GK, Remus LS, Jurutka PW, et al. (2001). Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol, 177, 145–159.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chalmers MJ, Stayrook KR, et al. (2011). DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol, 18, 556–563.
   PubMed Web of Science ®Google Scholar
• Zmuda JM, Cauley JA, Ferrell RE. (2000). Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev, 22, 203–217.
   PubMed Web of Science ®Google Scholar